Sitagliptin Mitigates Total Body Irradiation-Induced Hematopoietic Injury in Mice

Sitagliptin, an inhibitor of the dipeptidyl peptidase IV (DPP4), has been implicated in the regulation of type 2 diabetes. However, the role and mechanism of sitagliptin administration in total body irradiation (TBI)- induced hematopoietic cells injury are unclear. In this study, we demonstrated tha...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Oxid Med Cell Longev
Auteurs principaux: Wang, Meifang, Dong, Yinping, Wu, Jing, Li, Hongyan, Zhang, Junling, Lu, Lu, Zhang, Yuanyang, Zhou, Zewei, Fan, Saijun, Li, Deguan, Meng, Aimin
Format: Artigo
Langue:Inglês
Publié: Hindawi 2020
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7397422/
https://ncbi.nlm.nih.gov/pubmed/32774687
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/8308616
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires